Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Bisel

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Drug Testing and Analysis|March 8, 2014
Characterization of the designer benzodiazepine diclazepam and preliminary data on its metabolism and pharmacokineticsBjoern Moosmann, Philippe Bisel, Volker Auwärter
Organic & Biomolecular Chemistry|July 18, 2008
The tert-butyl group in chemistry and biologyPhilippe Bisel, Loay Al-Momani, Michael Müller
Chirality|April 6, 2006
Bicyclic glutamic acid derivativesUdo Meyer, Philippe Bisel, Edgar Weckert, et al.
Forensic Science International|June 15, 2016
Separation and structural characterization of the new synthetic cannabinoid JWH-018 cyclohexyl methyl derivative "NE-CHMIMO" using flash chromatography, GC-MS, IR and NMR spectroscopyVerena Angerer, Philippe Bisel, Bjoern Moosmann, et al.
Forensic Toxicology|January 15, 2019
5F-Cumyl-PINACA in 'e-liquids' for electronic cigarettes: comprehensive characterization of a new type of synthetic cannabinoid in a trendy product including investigations on the in vitro and in vivo phase I metabolism of 5F-Cumyl-PINACA and its non-fluorinated analog Cumyl-PINACAVerena Angerer, Florian Franz, Bjoern Moosmann, et al.
Drug Testing and Analysis|February 21, 2019
Method validation and preliminary pharmacokinetic studies on the new designer stimulant 3-fluorophenmetrazine (3-FPM)Christina Grumann, Laura M Huppertz, Philippe Bisel, et al.
Journal of Mass Spectrometry : JMS|August 19, 2016
Characterization and in vitro phase I microsomal metabolism of designer benzodiazepines - an update comprising adinazolam, cloniprazepam, fonazepam, 3-hydroxyphenazepam, metizolam and nitrazolamBjoern Moosmann, Philippe Bisel, Florian Franz, et al.
Journal of Mass Spectrometry : JMS|February 24, 2012
Identification and structural characterization of the synthetic cannabinoid 3-(1-adamantoyl)-1-pentylindole as an additive in 'herbal incense'Stefan Kneisel, Folker Westphal, Philippe Bisel, et al.
Chembiochem : a European Journal of Chemical Biology|July 28, 2022
Biosynthesis of Menaquinone in E. coli: Identification of an Elusive Isomer of SEPHCHCAlexander Fries, Laura S Mazzaferro, Philippe Bisel, et al.
Drug Testing and Analysis|December 23, 2018
Characterization and in vitro phase I microsomal metabolism of designer benzodiazepines: An update comprising flunitrazolam, norflurazepam, and 4'-chlorodiazepam (Ro5-4864)Bjoern Moosmann, Philippe Bisel, Folker Westphal, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Drug Testing and Analysis|March 8, 2014
Characterization of the designer benzodiazepine diclazepam and preliminary data on its metabolism and pharmacokineticsBjoern Moosmann, Philippe Bisel, Volker Auwärter
Organic & Biomolecular Chemistry|July 18, 2008
The tert-butyl group in chemistry and biologyPhilippe Bisel, Loay Al-Momani, Michael Müller
Chirality|April 6, 2006
Bicyclic glutamic acid derivativesUdo Meyer, Philippe Bisel, Edgar Weckert, et al.
Forensic Science International|June 15, 2016
Separation and structural characterization of the new synthetic cannabinoid JWH-018 cyclohexyl methyl derivative "NE-CHMIMO" using flash chromatography, GC-MS, IR and NMR spectroscopyVerena Angerer, Philippe Bisel, Bjoern Moosmann, et al.
Forensic Toxicology|January 15, 2019
5F-Cumyl-PINACA in 'e-liquids' for electronic cigarettes: comprehensive characterization of a new type of synthetic cannabinoid in a trendy product including investigations on the in vitro and in vivo phase I metabolism of 5F-Cumyl-PINACA and its non-fluorinated analog Cumyl-PINACAVerena Angerer, Florian Franz, Bjoern Moosmann, et al.
Drug Testing and Analysis|February 21, 2019
Method validation and preliminary pharmacokinetic studies on the new designer stimulant 3-fluorophenmetrazine (3-FPM)Christina Grumann, Laura M Huppertz, Philippe Bisel, et al.
Journal of Mass Spectrometry : JMS|August 19, 2016
Characterization and in vitro phase I microsomal metabolism of designer benzodiazepines - an update comprising adinazolam, cloniprazepam, fonazepam, 3-hydroxyphenazepam, metizolam and nitrazolamBjoern Moosmann, Philippe Bisel, Florian Franz, et al.
Journal of Mass Spectrometry : JMS|February 24, 2012
Identification and structural characterization of the synthetic cannabinoid 3-(1-adamantoyl)-1-pentylindole as an additive in 'herbal incense'Stefan Kneisel, Folker Westphal, Philippe Bisel, et al.
Chembiochem : a European Journal of Chemical Biology|July 28, 2022
Biosynthesis of Menaquinone in E. coli: Identification of an Elusive Isomer of SEPHCHCAlexander Fries, Laura S Mazzaferro, Philippe Bisel, et al.
Drug Testing and Analysis|December 23, 2018
Characterization and in vitro phase I microsomal metabolism of designer benzodiazepines: An update comprising flunitrazolam, norflurazepam, and 4'-chlorodiazepam (Ro5-4864)Bjoern Moosmann, Philippe Bisel, Folker Westphal, et al.
Pageof 2